On June 24, 2026, Vernus AI made its first appearance at BIO International Convention, the world's largest biotechnology event. The company showcased ReAIX, its proprietary AI-powered pharmaceutical manufacturing platform, engaging in business discussions with multinational pharma companies and biotech partners across North America, Europe, and Asia-Pacific. ReAIX integrates three core technologies — AI Agents, quantum computing, and physics simulation — to deliver a high-fidelity digital twin manufacturing platform. Several partnership discussions initiated at the event have since advanced to in-depth evaluation.

Source: Global Biotech & Investment Monthly｜June 25, 2026

Original Article: https://news.gbimonthly.com/tw/article/show.php?num=87720